丹红注射液治疗心肌缺血的疗效评价  

Evaluation of Clinical Efficacy of Danhong Injection for SMI

作　　者：王彩云 

机构地区：[1]云南省文山州丘北县人民医院,云南丘北663200

出　　处：《航空航天医学杂志》2015年第2期154-155,共2页Journal of Aerospace medicine

摘　　要：目的研究100例心肌缺血（SMI）患者采用丹红注射液合治疗的临床疗效。方法选取2012~2014年收治的心肌缺血患者100例,其中50例标记为对照组,给予基础治疗;其余50例患者给予丹红注射液治疗标记为观察组。结果疗程结束后两组进行心电图检测,观察组在恢复效果明显优于对照组（P〈0.05）;两组患者在不同药物使用下经过治疗后统计发现,观察组患者使用丹红注射液治疗总有效率为92%;对照组患者基础治疗总有效率仅为50%,两组对比,疗效存在显著性差异（P〈0.05）。结论脑醒静联合丹红注射液治疗脑梗死临床效果较好,优于其他药物。Objective To study the clinical efficacy of Danhong injection for 100 patients with SMI in our hospi- tal. Methods 100 patients with SMI treated from 2012 to 2014 in our hospital were selected and divided into observation group and control group, 50 cases each group. The control group received the basic therapy; the observation group were treated with Danhong injection. Results After treatment, ECG detection was conducted. The recovery effect of observa- tion group was significantly better than that of control group （ P 〈 0. 05 ） ; the total effective rate of observation group （92%） was significantly higher than that of control group （50%） （ P 〈 0.05 ）. Conclusions For treatment of cerebral infarction, Xingnaojing injection combined with Danhong injection have a better clinical efficacy than other drugs.

关 键 词：冠心病 丹红注射液 心肌缺血阈值 疗效观察 

分 类 号：R542.2[医药卫生—心血管疾病]